Research Triangle Park, NC 03|07|02

SciQuest, Inc. (NASDAQ: SQST), a software, information and services company that provides solutions to enhance research operations for pharmaceutical, biotechnology and other research-based organizations, announced today that Dr. Robert Gross has accepted an invitation to address BioIT World, one of the nation’s most prestigious information technology events focused on the life sciences, being held at the World Trade Center in Boston, March 12-14, 2002. Dr. Gross recently joined the SciQuest team through the Company’s acquisition of Textco, where he was founder and president.

Dr. Gross will deliver a presentation entitled "Sequence manipulation & analysis tools that molecular biologists can use intuitively with minimal support." His talk will examine the complex issues facing molecular biologists as they use computer analysis tools and discuss approaches and solutions based on intuitive software applications. Dr. Gross is speaking on Wednesday, March 13 at 11:00 a.m.

Dr. Gross will also be a panelist for the BioIT World CEO roundtable, March 13 from 8:00 am to 9:00 a.m. Those wishing to attend either Dr. Gross’ presentation or the CEO roundtable should contact Stephen Scarantino (contact information below). Dr. Gross will also be available for meetings and product demonstrations at booth #634 on Wednesday, March 13 and Thursday, March 14.

Dr. Robert Gross is a professor of Biological Sciences at Dartmouth College, where he is also the Director of the Center for Biological and Biomedical Computing. He is on the Scientific Advisory Boards of the Norris Cotton Cancer Center at Dartmouth-Hitchcock Memorial Hospital and the Dysautonomia Foundation. Dr. Gross has published over 35 scientific research papers in the fields of snRNAs, RNA splicing, heat shock, thermotolerance, and computational biology. In 1998, Dr. Gross received a Career Achievement Award from the Biotechnology Software and Internet Journal for "outstanding achievements in design, programming, and advancements in scientific software." Dr. Gross holds a B.E.S. degree in Engineering Sciences, an M.S. degree in Biomedical Engineering from Rensselaer Polytechnic Institute, and a Ph.D. in Biophysics from Johns Hopkins University.

SciQuest's Intuitive Software Solutions for Molecular Biologists:
SciQuest Gene Construction Kit™ (GCK), with its intuitive graphical interface, is a unique DNA manipulation, cloning design, and illustration tool. GCK provides molecular biologists with an intuitive way to design and track the complex process of gene cloning projects. By using GCK’s desktop cloning approach to experimental design, researchers can increase productivity and reduce research materials costs. GCK, through its powerful, built-in GenBank searching capabilities and its sophisticated importing capability, enables molecular biologists to work with the latest DNA sequence information only available via the internet. GCK is available for both Macintosh and Windows platforms.

SciQuest Gene Inspector™ (GI) combines a powerful sequence analysis package with a versatile electronic research notebook for molecular biologists. The innovative notebook design, featuring a comprehensive word processor, allows the import of images, gel electrophoresis images, and graphical constructs, and provides its own drawing and table tools making it the ideal place to record daily laboratory notes and procedures. GI offers more than 60 built-in nucleic acid and protein analyses, a sophisticated multiple sequence editor, and Internet database searching. The application can perform similarity searches such as BLAST, BLOCKS, FASTA, GRAIL, and SIGNALP directly over the Internet. Researchers can define and save suites of analyses with standardized sets of parameters and confidently rely upon Gene Inspector’s "Hotlinking" functionality to automatically update these analyses each time a sequence is changed. This means that everyone in a research group will be able to get relevant and consistent results. GI is available for Macintosh.

About SciQuest
SciQuest is a software, information and services company that provides solutions to enhance research operations for pharmaceutical, biotechnology and other research-based organizations. SciQuest is focused on enabling researchers and their organizations to reduce costs, improve efficiencies, increase quality and speed the process of research.

The Company’s solutions are specifically designed to help scientists find, acquire and manage the critical research materials they use. These materials include chemical and biological compounds, laboratory supplies, and equipment.

SciQuest also helps the suppliers of research materials to better service their customers through enhanced marketing channels and enriched product information.

The Company’s solutions can be utilized independently or integrated with leading software, automation equipment and supplier systems to enhance innovation, reduce costs and improve operational effectiveness.

Customers of SciQuest include many of the world’s leading pharmaceutical, biotechnology, chemical, academic and research organizations, such as Aventis, Bayer (Aventis CropScience), The Burnham Institute, Corixa, Eisai Research Institute, FMC, GlaxoSmithKline, Memorial Sloan-Kettering, OSI Pharmaceuticals, Roche, Pfizer, Procter & Gamble and Schering-Plough. SciQuest is headquartered in Research Triangle Park, N.C., with offices in Philadelphia and London. For more information about SciQuest, please visit www.sciquest.com or call +1-919-659-2100.

SciQuest is a registered trademark of SciQuest, Inc. Enterprise Reagent Manager, Enterprise Substance Manager, ERM Fast Track, ERM Fast Track Plus, SelectSite, SelectSite SRA, SelectSite APA, Gene Construction Kit and Gene Inspector are trademarks of SciQuest, Inc.

Statements in this press release that are not historical facts are forward-looking statements that involve risks and uncertainties. For such statements, the Company claims the protection of the safe harbor for forward-looking statements under the Private Securities Litigation Reform Act of 1995. The potential risks and uncertainties associated with these forward-looking statements could cause actual results to differ materially from those presented herein, and the reported results should not be considered as an indication of future performance. Factors that could cause actual results to differ from those contained in the forward-looking statements are discussed in the Company's Quarterly Report on Form 10-Q for the period ended September 30, 2001, filed with the Securities and Exchange Commission, under the caption "Factors That May Affect Future Results".

Textco, Inc. has been developing high quality molecular biology software for the Macintosh since 1984.